Date

2-7-2024

Department

School of Nursing

Degree

Doctor of Nursing Practice (DNP)

Chair

Debbie Maddox

Keywords

Ozempic, Type 2 diabetes, Lifestyle modification, Obesity, Diabetic management

Disciplines

Nursing

Abstract

A condition with observed poor management by most who possess a diagnosis, diabetes mellitus remains the seventh leading cause of death within the country. This diagnosis can and often does lead to severe complications, creating implications for not only the patient but also families, caregivers, and the community. Most diabetic patients possess a diagnosis of type 2 diabetes mellitus. The healthcare industry continues to implement improvement with diabetic management and complications resulting from diabetes. Research suggests that the standard of care for patients with diabetes begins with lifestyle modification to improve glycemic control. New medications, such as Ozempic (semaglutide), have also been influential in diabetic management. Therefore, this scholarly project intended to study the two methods of medication management with GLP1-RA Ozempic and diabetic educational information with the hopes of improved glycemic control, improved weight, and improved comprehension of lifestyle management of the diagnosis. Patients were tracked for a period of 12 weeks, assessing pre- and post-study data. The data collected included A1C, weight in pounds, body mass index (BMI), and self care knowledge via a validated questionnaire. Participants were to be on the medication Ozempic (semaglutide) and receive 12 weeks of educational emails. Each participant received one email weekly. This scholarly project proved to be statistically significant. Post study results reveal P values of 0.220 for BMI, 0.0310 for weight, 0.05 for A1C and 0.0001 for Self Care Inventory-Revised. These results support the pairing of GLP1_RA Ozempic with diabetic education.

Download

Included in

Nursing Commons

Share

COinS